BIO KOREA 2023: Registration Now Open for Business Partnering
10% discount for pre-registrations by May 5 SEOUL, South Korea--(BUSINESS WIRE)--#BIOKOREA--The Korea Health Industry Development…
3 years ago
Wire Stories
EPE & Lunar Outpost Oceania Consortium Selected to Participate in the Australian Space Agency’s Moon to Mars Trailblazer Initiative, Expanding International Space Relationship between US and Australia
Lunar Outpost and EPE will co-lead their consortium in supporting Australia’s first-ever mission to the…
3 years ago
Transphorm Releases 3 kW Inverter Board with Microchip’s Digital Signal Controller, Continuing High Power GaN Leadership
Evaluation Board with SuperGaN® FET and dsPIC® DSC Simplifies and Quickens Development of High Voltage…
3 years ago
Epsilon Named a Leader in Loyalty Technology Solutions Report by Independent Research Firm
~ Epsilon Achieves Highest Score in Strategy Category, Highest Scores Possible in 15 Criteria Including…
3 years ago
Carbon Revolution Posts Replay of Evercore ISI Fireside Chat
GEELONG, Australia & NAPLES, Fla.--(BUSINESS WIRE)--Carbon Revolution Limited (“CBR”, “Carbon Revolution” or the “Company”) (ASX:…
3 years ago
India Water Purifier Market Report 2023: Rising Awareness of Waterborne Diseases Fuels Growth – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "India Water Purifier Market | Trends, Value, Revenue, Outlook, Forecast, Size, Analysis, Growth,…
3 years ago
Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
Third positive registrational trial met its primary endpoint, with KarXT demonstrating an 8.4-point reduction in…
3 years ago
Capstone Copper Announces New Sustainable Development Strategy and GHG Emissions Reduction Targets
VANCOUVER, British Columbia--(BUSINESS WIRE)--#CapstoneCopper--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) is pleased to announce…
3 years ago
Coya Therapeutics, Inc. Announces an Agreement with Dr. Reddy’s Laboratories, Ltd. to License its proposed biosimilar Abatacept for the Development and Commercialization of COYA 302 for the Treatment of Neurodegenerative Diseases
COYA 302 is an investigational combination biologic for subcutaneous administration, comprised of COYA 301 and…
3 years ago
Malaysia Social Commerce Market Intelligence and Future Growth Dynamics Databook Q1 2023 Update: Sector to Reach $4.4 Billion by 2028 at a 21% CAGR – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Malaysia Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs…
3 years ago